Silencing of circular RNA PUM1 inhibits clear cell renal cell carcinoma progression through the miR-340-5p/FABP7 axis

References

• Reustle A, Di Marco M, Meyerhoff C, et al. Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy. Genome Med. 2020;12(1):32.
   PubMed Web of Science ®Google Scholar
• Ye Z, Duan J, Wang L, et al. LncRNA-LET inhibits cell growth of clear cell renal cell carcinoma by regulating miR-373-3p. Cancer Cell Int. 2019;19:311.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wu J, Wu C, et al. The LINC01138 interacts with PRMT5 to promote SREBP1-mediated lipid desaturation and cell growth in clear cell renal cell carcinoma. Biochem Biophys Res Commun. 2018;507(1-4):337–342.
   PubMed Web of Science ®Google Scholar
• Radic TM, Coric VM, Pljesa-Ercegovac MS, et al. Concomitance of polymorphisms in glutathione transferase omega genes is associated with risk of clear cell renal cell carcinoma. Tohoku J Exp Med. 2018;246(1):35–44.
   PubMed Web of Science ®Google Scholar
• Campagna R, Cecati M, Pozzi V, et al. Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma. Cell Mol Biol (Noisy-le-Grand). 2018;64(7):51–55.
   PubMed Web of Science ®Google Scholar
• Yu DP, Zhou Y. Astrocyte elevated gene 1 (AEG-1) acts as a promoter gene in clear cell renal cell carcinoma cell growth and metastasis. Med Sci Monit. 2018;24:8213–8223.
   PubMed Web of Science ®Google Scholar
• Chen L, Yuan L, Qian K, et al. Identification of biomarkers associated with pathological stage and prognosis of clear cell renal cell carcinoma by co-expression network analysis. Front Physiol. 2018;9:399.
   PubMed Web of Science ®Google Scholar
• Qu S, Liu Z, Yang X, et al. The emerging functions and roles of circular RNAs in cancer. Cancer Lett. 2018;414:301–309.
   PubMed Web of Science ®Google Scholar
• Liu J, Li D, Luo H, et al. Circular RNAs: the star molecules in cancer. Mol Aspects Med. 2019;70:141–152.
   PubMed Web of Science ®Google Scholar
• Chen J, Xu S, Chen S, et al. CircPUM1 promotes the malignant behavior of lung adenocarcinoma by regulating miR-326. Biochem Biophys Res Commun. 2019;508(3):844–849.
   PubMed Web of Science ®Google Scholar
• Guan X, Zong ZH, Liu Y, et al. circPUM1 promotes tumorigenesis and progression of ovarian cancer by sponging miR-615-5p and miR-6753-5p. Mol Ther Nucleic Acids. 2019;18:882–892.
   PubMedGoogle Scholar
• Zhong Y, Du Y, Yang X, et al. Circular RNAs function as ceRNAs to regulate and control human cancer progression. Mol Cancer. 2018;17(1):79.
   PubMed Web of Science ®Google Scholar
• Oto J, Plana E, Sanchez-Gonzalez JV, et al. Urinary microRNAs: looking for a new tool in diagnosis, prognosis, and monitoring of renal cancer. Curr Urol Rep. 2020;21(2):11.
   PubMed Web of Science ®Google Scholar
• Awasthi R, Rathbone MJ, Hansbro PM, et al. Therapeutic prospects of microRNAs in cancer treatment through nanotechnology. Drug Deliv Transl Res. 2018;8(1):97–110.
   PubMed Web of Science ®Google Scholar
• Shiomi E, Sugai T, Ishida K, et al. Analysis of expression patterns of microRNAs that are closely associated with renal carcinogenesis. Front Oncol. 2019;9:431.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li X, Zhang Y, et al. An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme. Oncogene. 2019;38(49):7399–7415.
   PubMed Web of Science ®Google Scholar
• Lu G, Zhang Y. MicroRNA-340-5p suppresses non-small cell lung cancer cell growth and metastasis by targeting ZNF503. Cell Mol Biol Lett. 2019;24:34.
   PubMed Web of Science ®Google Scholar
• Hao JF, Ren KM, Bai JX, et al. Identification of potential biomarkers for clear cell renal cell carcinoma based on microRNA-mRNA pathway relationships. J Cancer Res Ther. 2014;10(Suppl):C167–77.
   PubMedGoogle Scholar
• Zhang Y, Wang D, Zhu T, et al. CircPUM1 promotes hepatocellular carcinoma progression through the miR-1208/MAP3K2 axis. J Cell Mol Med. 2020. [Online ahead of print].
   Web of Science ®Google Scholar
• Zong ZH, Liu Y, Chen S, et al. Circ_PUM1 promotes the development of endometrial cancer by targeting the miR-136/NOTCH3 pathway. J Cell Mol Med. 2020;24(7):4127–4135.
   PubMed Web of Science ®Google Scholar
• Liu D, Lin L, Wang Y, et al. PNO1, which is negatively regulated by miR-340-5p, promotes lung adenocarcinoma progression through Notch signaling pathway. Oncogenesis. 2020;9(5):58.
   PubMed Web of Science ®Google Scholar
• Liu L, Yan Y, Zhang G, et al. Knockdown of LINC01694 inhibits growth of gallbladder cancer cells via miR-340-5p/Sox4. Biosci Rep. 2020;40(4):BSR2019444.
   Web of Science ®Google Scholar
• Rongxin S, Pengfei L, Li S, et al. MicroRNA-340-5p suppresses osteosarcoma development by down-regulating the Wnt/β-catenin signaling pathway via targeting the STAT3 gene. Eur Rev Med Pharmacol Sci. 2019;23(3):982–991.
   PubMed Web of Science ®Google Scholar
• Nagao K, Shinohara N, Smit F, et al. Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma. BMC Cancer. 2018;18(1):1114.
   PubMedGoogle Scholar
• Takaoka N, Takayama T, Ozono S. Functional analysis of fatty acid binding protein 7 and its effect on fatty acid of renal cell carcinoma cell lines. BMC Cancer. 2017;17(1):192.
   PubMedGoogle Scholar
• Zhou J, Deng Z, Chen Y, et al. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma. Urol Oncol. 2015;33:113 e9–17.
   PubMed Web of Science ®Google Scholar
• Chen YC, Chien LH, Huang BM, et al. Aqueous extracts of toona sinensis leaves inhibit renal carcinoma cell growth and migration through JAK2/stat3, Akt, MEK/ERK, and mTOR/HIF-2α pathways. Nutr Cancer. 2016;68(4):654–666.
   PubMed Web of Science ®Google Scholar
• Pengcheng S, Ziqi W, Luyao Y, et al. MicroRNA-497 suppresses renal cell carcinoma by targeting VEGFR-2 in ACHN cells. Biosci Rep. 2017;37(3):BSR20170270.
   PubMedGoogle Scholar
• Sun P, Wang L, Lu Y, et al. MicroRNA-195 targets VEGFR2 and has a tumor suppressive role in ACHN cells via PI3K/Akt and Raf/MEK/ERK signaling pathways. Int J Oncol. 2016;49(3):1155–1163.
   PubMed Web of Science ®Google Scholar
• Ma R, Wang L, Yuan F, et al. FABP7 promotes cell proliferation and survival in colon cancer through MEK/ERK signaling pathway. Biomed Pharmacother. 2018;108:119–129.
   PubMed Web of Science ®Google Scholar
• Qin S, Shi X, Wang C, et al. Transcription factor and miRNA interplays can manifest the survival of ccRCC patients. Cancers (Basel). 2019;11(11):1668.
   Web of Science ®Google Scholar
• Song H, Liu Q, Liao Q. Circular RNA and tumor microenvironment. Cancer Cell Int. 2020;20:211.
   PubMed Web of Science ®Google Scholar
• Tang Q, Hann SS. Biological roles and mechanisms of circular RNA in human cancers. Onco Targets Ther. 2020;13:2067–2092.
   PubMed Web of Science ®Google Scholar
• Deng L, Chen Q, Xie J, et al. circPUM1 promotes polycystic ovary syndrome progression by sponging to miR-760. Gene. 2020;754:144903.
   PubMed Web of Science ®Google Scholar
• Yang L, Men WL, Yan KM, et al. MiR-340-5p is a potential prognostic indicator of colorectal cancer and modulates ANXA3. Eur Rev Med Pharmacol Sci. 2018;22(15):4837–4845.
   PubMed Web of Science ®Google Scholar
• Jian X, He H, Zhu J, et al. Hsa_circ_001680 affects the proliferation and migration of CRC and mediates its chemoresistance by regulating BMI1 through miR-340. Mol Cancer. 2020;19(1):20.
   PubMed Web of Science ®Google Scholar
• Ahn J, Lee H, Jung CH, et al. Lycopene inhibits hepatic steatosis via microRNA-21-induced downregulation of fatty acid-binding protein 7 in mice fed a high-fat diet. Mol Nutr Food Res. 2012;56(11):1665–1674.
   PubMed Web of Science ®Google Scholar
• Song L, Zhou Z, Gan Y, et al. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p. J Cell Biochem. 2019;120(6):9656–9666.
   PubMed Web of Science ®Google Scholar